2C-AL
# 2C-AL

2C-AL is a drug from the substituted phenethylamine family which acts as an agonist of the $5-HT_{2A}$ receptor, with an $EC_{50}$ of 2.15nM at $5-HT_{2A}$ vs 77.71nM at $5-HT_{2B},$ and produces a head-twitch response in animal studies. It was first discussed as a hypothetical compound in Daniel Trachsel's 2013 review of the field after his successful synthesis of the related compounds 2C-V and 2C-YN, and finally synthesised by a team at Gilgamesh Pharmaceuticals in 2020 using a different synthetic route from that employed by Trachsel.

